Clinical trial Recruiting at 1 site Observational Ages 24 Months and up

MRI analysis of individuals with autism and their families

Official title: Magnetic Resonance Imaging Neuroanatomical Study of Patients with an Autism Spectrum Disorder, Their Relatives and Typically Developing Subjects.

Run by Institut National de la Santé Et de la Recherche Médicale, France · NCT05470088 · Data updated 2026-11-12

This study is trying to see if brain scans can help us understand the genetic and clinical features of autism in people with the condition and their families.

More Autism Spectrum Disorder trials

Quick facts

Study typeObservational
Ages24 Months and up
SexAll
Enrollment1000 (estimated)
SponsorInstitut National de la Santé Et de la Recherche Médicale, France
Government
Locations2 sites (Gif-sur-Yvette and 1 other locations)
StatusRecruiting
StartedMarch 13, 2022
Main results expectedMarch 13, 2037
Study endsSeptember 13, 2039
Registry record updatedMarch 13, 2025
Trial IDNCT05470088 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals diagnosed with ASD who are part of the main genetic study and are at least 24 months old.

Probably not a fit

Patients who do not meet the diagnostic criteria for ASD or are not part of the main genetic study may not benefit from this research.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project focuses on understanding the genetic and clinical aspects of Autism Spectrum Disorder (ASD) through neuroimaging techniques. It involves acquiring anatomical, diffusion, and functional MRI data from individuals diagnosed with ASD, their relatives, and control subjects. The study is part of a larger initiative examining genetic factors associated with ASD, leveraging data from over 600 previously recruited participants. The research aims to identify brain abnormalities linked to ASD and their heritability.

Why it matters

Potential benefit: If successful, this study could enhance our understanding of the neurobiological underpinnings of autism, potentially leading to improved diagnostic and therapeutic strategies.

How similar studies have gone: Previous studies utilizing neuroimaging to explore ASD have shown promising results, indicating that this approach is both relevant and potentially impactful.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* for patients:

  * being included in the main study "C16-89 - Study of genetic factors involved in ASD and related disorders"
  * having an ASD fulfilling DSM-5 diagnostic criteria (APA, 2012). Diagnosis will be done by a clinical expert, with the support of structured instruments (ADI-R, ADOS-2)
  * having at least 24 Months
  * being affiliated with the French health insurance
  * having signed the informed consent (by proposant or by legal tutors if the subject is \<18 or under legal custody)
* for relatives

  * being included in the main study "C16-89 - Study of genetic factors involved in ASD and related disorders"
  * having at least 24 Months
  * being affiliated with the French health insurance
  * having signed the informed consent (by proposant or by legal tutors if the subject is \<18 or under legal custody)
* for controls

  * being included in the main study "C16-89 - Study of genetic factors involved in ASD and related disorders"
  * having at least 24 Months
  * being affiliated with the French health insurance
  * having signed the informed consent (by proposant or by legal tutors if the subject is \<18 or under legal custody)

Non-inclusion criteria:

* for all subjects

  * severe mental retardation (IQ\<35 or developmental age\<18 months)
  * medical condition (either psychiatric or physical) not compatible with an inclusion
  * MRI counter indication
  * Current pregnancy or breastfeeding, assessed by questionnaire
  * Not willing to be informed of a brain abnormality diagnosed with MRI
* for the relatives

  \*discovery of non filiation during the genetic analyses
* for controls

  * Neurological history (except mental retardation)
  * Personal history of (checked with DIGS for Adults, Diagnostic Interview for Genetic Studies, Numberger et coll., 1994, or Kiddie SADS, Kiddie Schedule for Disorders and Schizophrenia for School Age Children, Orvaschel et coll., 1982): schizophrenia, addiction, bipolar disorder, recurrent depression (\> 2 episodes lifetime), severe, not stabilized anxiety disorder, history of episodes of epilepsy, significant inflammatory disease of immunosuppressive medication

Exclusion Criteria:

* for patients: ASD diagnosis not confirmed by assessments after the inclusion
* for all subjects: discovery of a counter indication to MRI during the exam (e.g. claustrophobia)

Where it's running

  • APHP, Hôpital Robert Debré
    Paris, France
    Recruiting
  • NeuroSpin neuroimaging platforme
    Gif-sur-Yvette, France
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.